Investment analysts at StockNews.com began coverage on shares of Arch Biopartners (NYSE:ARCH – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating on the stock.
Arch Biopartners Price Performance
ARCH opened at $134.83 on Tuesday. Arch Biopartners has a 12-month low of $116.44 and a 12-month high of $180.65.
Read More
- Five stocks we like better than Arch Biopartners
- Stock Splits, Do They Really Impact Investors?
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Are Tariffs Threatening Disney’s Comeback Story?
- Find and Profitably Trade Stocks at 52-Week Lows
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Arch Biopartners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Biopartners and related companies with MarketBeat.com's FREE daily email newsletter.
